P. Lagacé-Wiens

发表

Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11.

M. Mulvey, J. Blondeau, D. Low, 2013, The Journal of antimicrobial chemotherapy.

Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2011, Antimicrobial Agents and Chemotherapy.

Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, The Journal of antimicrobial chemotherapy.

Antimicrobial Resistance in Urinary Tract Pathogens in Canada from 2007 to 2009: CANWARD Surveillance Study

Patricia J. Simner, J. Karlowsky, D. Hoban, 2011, Antimicrobial Agents and Chemotherapy.

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2016, Drugs.

Extended-Spectrum Beta-Lactamase Producing Escherichia coli : Increasing Incidence of a Resistant Pathogen

J. Karlowsky, P. Lagacé-Wiens, A. Walkty, 2016 .

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

S. Trottier, M. Loeb, B. Light, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Mycobacterium Mucogenicum Bacteremia and Nodular Soft Tissue Infection in a Person Who Uses Tap Water to Inject Drugs

P. Lagacé-Wiens, Carl Boodman, Catherine Smith, 2020, Open forum infectious diseases.

ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in Manitoba.

M. Mulvey, L. Nicolle, M. Alfa, 2007, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Presence of the narrow-spectrum OXA-1 β-lactamase enzyme is associated with elevated piperacillin/tazobactam MIC values among ESBL-producing Escherichia coli clinical isolates (CANWARD, 2007–18)

M. Mulvey, J. Karlowsky, P. Lagacé-Wiens, 2022, JAC-antimicrobial resistance.

Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007–19

M. Mulvey, Denice C. Bay, J. Karlowsky, 2022, JAC-antimicrobial resistance.

Use of Fosfomycin Etest To Determine In Vitro Susceptibility of Clinical Isolates of Enterobacterales Other than Escherichia coli, Nonfermenting Gram-Negative Bacilli, and Gram-Positive Cocci

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2021, Journal of clinical microbiology.

Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2020, Journal of Clinical Microbiology.

Campylobacter concisus gastritis masquerading as Helicobacter pylori on gastric biopsy

P. Lagacé-Wiens, Julianne R H Klein, Elizabeth O Ferreira, 2021, Helicobacter.

Prevalence, predictors, and consequences of inappropriate empiric antimicrobial therapy for complicated urinary tract and intra-abdominal infections in Winnipeg hospitals.

C. Righolt, P. Lagacé-Wiens, S. Mahmud, 2019, Diagnostic microbiology and infectious disease.

Reductions in Workload and Reporting Time by Use of Methicillin-Resistant Staphylococcus aureus Screening with MRSASelect Medium Compared to Mannitol-Salt Medium Supplemented with Oxacillin

K. Manickam, G. Harding, M. Alfa, 2008, Journal of Clinical Microbiology.

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, The Journal of antimicrobial chemotherapy.

In Vitro Activity of Ceftaroline against Gram-Positive and Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2011, Antimicrobial Agents and Chemotherapy.

Bacterial Nomenclature - A Moving Target?

J. Karlowsky, M. Alfa, P. Lagacé-Wiens, 2013 .

Evaluation of the Hologic Aptima Combo 2 Assay for Detection of Neisseria gonorrhoeae from Joint Fluid Specimens

P. V. Van Caeseele, I. Martin, J. Karlowsky, 2022, Journal of clinical microbiology.

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, Drugs.

Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.

M. Mulvey, J. Pitout, J. Karlowsky, 2013, The Journal of antimicrobial chemotherapy.

In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2011, Antimicrobial Agents and Chemotherapy.

Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series

Y. Keynan, A. Dibernardo, R. Lindsay, 2022, CMAJ open.

Evaluation of MRSASelect (™) chromogenic medium for the early detection of methicillin-resistant Staphylococcus aureus from blood cultures.

K. Manickam, J. Karlowsky, M. Alfa, 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, Drugs.

Adverse reactions to β-lactam antimicrobials

P. Lagacé-Wiens, E. Rubinstein, 2012, Expert opinion on drug safety.

Characterization of isolates of Eisenbergiella tayi, a strictly anaerobic Gram-stain variable bacillus recovered from human clinical materials in Canada.

L. Hoang, K. Bernard, T. Burdz, 2017, Anaerobe.

Inﬂuenza epidemiology—past, present, and future

A. Gumel, P. Lagacé-Wiens, E. Rubinstein, 2010 .

Recovered from Multiple Medical Centers Associated with Abscess Formation and Anaerobic Gram-Positive Bacillus Novel Fastidious, Partially Acid-Fast,

S. Richter, K. Bernard, P. Lagacé-Wiens, 2014 .

Novel Fastidious, Partially Acid-Fast, Anaerobic Gram-Positive Bacillus Associated with Abscess Formation and Recovered from Multiple Medical Centers

K. Bernard, A. Schuetz, P. Lagacé-Wiens, 2013, Journal of Clinical Microbiology.

Thermostable DNase Is Superior to Tube Coagulase for Direct Detection of Staphylococcus aureus in Positive Blood Cultures

K. Manickam, J. Karlowsky, M. Alfa, 2007, Journal of Clinical Microbiology.

Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19.

P. V. Van Caeseele, P. Lagacé-Wiens, J. Bullard, 2021, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2016, Drugs.

The microbiology of endophthalmitis: global trends and a local perspective

Y. Keynan, P. Lagacé-Wiens, Y. Finkelman, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019

M. Mulvey, Denice C. Bay, J. Karlowsky, 2022, Microbiology spectrum.

In vitro activity of ceftolozane/tazobactam versus antimicrobial non-susceptible Pseudomonas aeruginosa clinical isolates including MDR and XDR isolates obtained from across Canada as part of the CANWARD study, 2008–16

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2018, The Journal of antimicrobial chemotherapy.

Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia

P. Lagacé-Wiens, E. Rubinstein, 2013, Expert opinion on drug metabolism & toxicology.

The microbiology of endophthalmitis: global trends and a local perspective

Y. Keynan, P. Lagacé-Wiens, Y. Finkelman, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2008, Expert review of anti-infective therapy.

Multifaceted antibiotic treatment analysis of methicillin-sensitive Staphylococcus aureus bloodstream infections.

R. Ariano, P. Lagacé-Wiens, S. Zelenitsky, 2016, International journal of antimicrobial agents.

Real-life experience with ceftobiprole in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry.

Y. Keynan, M. Bergevin, C. Tascini, 2021, Journal of global antimicrobial resistance.

difficile Infection Laboratory Diagnosis of Clostridium Comparison with the Illumigene Assay for Evaluation of an Algorithmic Approach in

K. Manickam, J. Karlowsky, M. Alfa, 2014 .

Evaluation of an Algorithmic Approach in Comparison with the Illumigene Assay for Laboratory Diagnosis of Clostridium difficile Infection

K. Manickam, J. Karlowsky, M. Alfa, 2013, Journal of Clinical Microbiology.

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

M. Gilmour, J. Karlowsky, D. Hoban, 2015, Drugs.

A case of vertical transmission of Chagas disease contracted via blood transfusion in Canada.

M. Ndao, P. Lagacé-Wiens, M. Fearon, 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America.

M. Mulvey, D. Boyd, D. Hoban, 2009, Diagnostic microbiology and infectious disease.

New Lipoglycopeptides

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2010, Drugs.

Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria

Denice C. Bay, J. Karlowsky, K. Naber, 2022, Drugs.

In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2018, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.

M. Mulvey, J. Karlowsky, D. Hoban, 2008, Diagnostic microbiology and infectious disease.

Evaluation of three MALDI‐TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada

R. Piarroux, A. Normand, M. Hendrickx, 2018, Mycoses.

Hemorrhagic pustules in an Aboriginal man

P. Lagacé-Wiens, Kerry Macdonald, J. Embil, 2014, Canadian Medical Association Journal.

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2017, Drugs.

Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.

M. Mulvey, J. Pitout, D. Hoban, 2011, Diagnostic microbiology and infectious disease.

Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.

M. Mulvey, J. Karlowsky, D. Hoban, 2019, The Journal of antimicrobial chemotherapy.

Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.

M. Mulvey, D. Hoban, P. Lagacé-Wiens, 2011, Diagnostic microbiology and infectious disease.

Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections

J. Karlowsky, P. Lagacé-Wiens, A. Walkty, 2014, Core evidence.

In Vitro Activity of Ceftaroline-Avibactam against Gram-Negative and Gram-Positive Pathogens Isolated from Patients in Canadian Hospitals from 2010 to 2012: Results from the CANWARD Surveillance Study

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, Antimicrobial Agents and Chemotherapy.

Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008)

Michael R. Mulvey, M. Mulvey, J. Karlowsky, 2010, Antimicrobial Agents and Chemotherapy.

Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.

M. Mulvey, L. Nicolle, P. Lagacé-Wiens, 2006, The Journal of antimicrobial chemotherapy.

First Description of an Extended-Spectrum-β-Lactamase-Producing Multidrug-Resistant Escherichia fergusonii Strain in a Patient with Cystitis

P. Lagacé-Wiens, G. Hammond, P. Pang, 2010, Journal of Clinical Microbiology.

Mechanical valve endocarditis caused by Gemella morbillorum.

P. Lagacé-Wiens, Ghanem Alhujailan, 2007, Journal of medical microbiology.

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada.

D. Hoban, P. Lagacé-Wiens, H. Adam, 2013, The Journal of antimicrobial chemotherapy.

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

J. Karlowsky, A. Noreddin, P. Lagacé-Wiens, 2019, Drugs.

Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia

L. Mandell, Denice C. Bay, J. Karlowsky, 2020, Drugs.

Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent

Denice C. Bay, J. Karlowsky, P. Lagacé-Wiens, 2020, Drugs.

Influenza epidemiology—past, present, and future

A. Gumel, P. Lagacé-Wiens, E. Rubinstein, 2010, Critical care medicine.

Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya.

J. Kimani, P. Lagacé-Wiens, G. Zhanel, 2012, Sexually transmitted diseases.

A non-healing nodule in a returned traveller

G. Harding, P. Lagacé-Wiens, 2006, Canadian Medical Association Journal.

A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1

G. Harding, P. Lagacé-Wiens, 2007, Canadian Medical Association Journal.

Human Ophthalmomyiasis Interna Caused by Hypoderma tarandi, Northern Canada

D. Colwell, P. Lagacé-Wiens, T. Galloway, 2008, Emerging infectious diseases.

Dientamoeba fragilis: an emerging role in intestinal disease

P. Lagacé-Wiens, C. Koschik, P. Vancaeseele, 2006, Canadian Medical Association Journal.

Inguinal Ulceroglandular Tularemia Caused by Francisella tularensis Subspecies holarctica, Canada

Y. Keynan, P. Lagacé-Wiens, S. Lother, 2021, Emerging infectious diseases.

Clonal Clusters and Virulence Factors of Group C and G Streptococcus Causing Severe Infections, Manitoba, Canada, 2012–2014

W. Demczuk, I. Martin, M. Mulvey, 2017, Emerging infectious diseases.

Changing trends in β-hemolytic streptococcal bacteremia in Manitoba, Canada: 2007-2012.

M. Gilmour, Y. Keynan, P. Lagacé-Wiens, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals: CANWARD 2008-2011.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2012, Diagnostic microbiology and infectious disease.

Emerging group C and group G streptococcal endocarditis: A Canadian perspective.

Y. Keynan, D. Jassal, P. Lagacé-Wiens, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

Michael R. Mulvey, M. Mulvey, J. Karlowsky, 2008, Antimicrobial Agents and Chemotherapy.

Marked elevation of serum ferritin associated with Anaplasma phagocytophilum infection.

R. Zarychanski, J. Karlowsky, P. Lagacé-Wiens, 2019, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.

M. Mulvey, Denice C. Bay, J. Karlowsky, 2019, The Journal of antimicrobial chemotherapy.

positive clinical isolates obtained from patients in Canadian hospitals as

D. Hoban, P. Lagacé-Wiens, H. Adam, 2014 .

Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2007)

Michael R. Mulvey, M. Mulvey, J. Karlowsky, 2009 .

In Vitro Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007 to 2012

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, Antimicrobial Agents and Chemotherapy.

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2009, Drugs.

Pasteurella species peritoneal dialysis-associated peritonitis: Household pets as a risk factor

P. Lagacé-Wiens, J. Embil, M. Verrelli, 2015, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential

I. Martin, M. Mulvey, J. Karlowsky, 2017, The Journal of antimicrobial chemotherapy.

Gardnerella vaginalis Bacteremia in a Previously Healthy Man: Case Report and Characterization of the Isolate

K. Bernard, A. Reimer, T. Burdz, 2007, Journal of Clinical Microbiology.

Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.

D. Low, J. Karlowsky, P. Lagacé-Wiens, 2009, International journal of antimicrobial agents.

Pertussis Testing: Pathogen and Laboratory Identification

P. Lagacé-Wiens, H. Adam, K. Nichol, 2015 .

Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, The Journal of antimicrobial chemotherapy.

Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006).

M. Mulvey, J. Karlowsky, D. Hoban, 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Impact of Frailty on Influenza Vaccine Effectiveness and Clinical Outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season

S. Trottier, M. Loeb, B. Light, 2016 .

Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study

M. Mulvey, J. Karlowsky, D. Hoban, 2018, The Journal of antimicrobial chemotherapy.

Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2011, Diagnostic microbiology and infectious disease.

In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2014, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2020, Diagnostic microbiology and infectious disease.

Identification of Blood Culture Isolates Directly from Positive Blood Cultures by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and a Commercial Extraction System: Analysis of Performance, Cost, and Turnaround Time

J. Karlowsky, M. Alfa, P. Lagacé-Wiens, 2012, Journal of Clinical Microbiology.

Influenza Vaccine Effectiveness in the Prevention of Influenza-Related Hospitalization in Canadian Adults Over the 2011/12 Through 2013/14 Season: A Pooled Analysis From the Serious Outcomes Surveillance (SOS) Network of the Canadian Influenza Research Network (CIRN)

S. Trottier, M. Loeb, B. Light, 2016 .

Re-evaluation of rejection criteria for endotracheal tube (ETT) specimens from adult patients.

K. Manickam, J. Karlowsky, M. Alfa, 2012, Journal of medical microbiology.

CHROMagar Orientation Medium Reduces Urine Culture Workload

K. Manickam, J. Karlowsky, M. Alfa, 2013, Journal of Clinical Microbiology.

2 ) 1 2 3 CHROMagar TM Orientation Media Reduces Urine Culture Workload 4 5

K. Manickam, J. Karlowsky, M. Alfa, 2013 .

Analysis of 1560 inpatient and outpatient Escherichia coli isolates from across Canada - Results from the CANWARD 2007 study

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2009 .

Differences in antimicrobial susceptibility in Escherichia coli from Canadian intensive care units based on regional and demographic variables.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2021, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibility of 2906 Pseudomonasaeruginosa clinical isolates obtained from patients in Canadian hospitals over a period of 8 years: Results of the Canadian Ward surveillance study (CANWARD), 2008-2015.

M. Mulvey, J. Karlowsky, P. Lagacé-Wiens, 2017, Diagnostic microbiology and infectious disease.

Clinical Blood Isolates from Hemodialysis Patients: Distribution of Organisms and Antimicrobial Resistance, 2007-2014.

R. Ariano, P. Lagacé-Wiens, S. Zelenitsky, 2020, The Canadian journal of hospital pharmacy.

Microbiological Trends and Antimicrobial Resistance in Peritoneal Dialysis-Related Peritonitis, 2005 to 2014

R. Ariano, P. Lagacé-Wiens, S. Zelenitsky, 2017, Peritoneal Dialysis International.

Empyema caused by Clostridium bifermentans: A case report

J. Karlowsky, P. Lagacé-Wiens, A. Walkty, 2015, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

In Vitro Activity of Fosfomycin against Escherichia coli Isolated from Patients with Urinary Tract Infections in Canada as Part of the CANWARD Surveillance Study

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, Antimicrobial Agents and Chemotherapy.

In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016.

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2019, International Journal of Antimicrobial Agents.

Epidemiology of Vancomycin-Resistant Enterococci in Canadian Hospitals (CANWARD Study, 2007 to 2013)

M. Gilmour, J. Karlowsky, D. Hoban, 2015, Antimicrobial Agents and Chemotherapy.

In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2022, Journal of Antimicrobial Chemotherapy.

Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF/MS)-based identification of pathogens from positive blood culture bottles.

P. Lagacé-Wiens, 2015, Methods in molecular biology.

CHROMagar™ orientation urine culture medium produces matrix-assisted laser desorption ionization-time-of-flight mass spectrometry spectra misidentified as Mycoplasma arginini and Mycoplasma alkalescens.

J. Karlowsky, P. Lagacé-Wiens, Amanda A Abbott, 2019, Diagnostic microbiology and infectious disease.

MALDI-ToF Mass Spectrometry : Microbiology and Physics Collide Prepared

P. Lagacé-Wiens, P. Pieroni, 2014 .

Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.

M. Mulvey, S. Poutanen, J. Karlowsky, 2019, The Journal of antimicrobial chemotherapy.

Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015).

M. Mulvey, S. Poutanen, J. Karlowsky, 2016, CMAJ open.

Diagnostic testing for SARS-CoV-2

P. Lagacé-Wiens, J. Bullard, Carl Boodman, 2020, Canadian Medical Association Journal.

In vitro susceptibility of common bacterial pathogens causing respiratory tract infections in Canada to lefamulin, a new pleuromutilin.

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2021, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2022, JAC-antimicrobial resistance.

Characterization of MRSA in Canada from 2007 to 2016.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2019, The Journal of antimicrobial chemotherapy.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults

S. Trottier, M. Loeb, A. Chit, 2019, Journal of medical microbiology.

Successful Treatment of Pulmonary Blastomycosis with Continuously Infused Amphotericin B Deoxycholate After Failure with Liposomal Amphotericin B

R. Ariano, P. Lagacé-Wiens, S. Zelenitsky, 2013, The Annals of pharmacotherapy.

Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada.

P. Lagacé-Wiens, L. Lee, Andrea Nwosu, 2021, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada.

P. Lagacé-Wiens, L. Lee, Andrea Nwosu, 2021, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Ceftaroline

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2012, Drugs.

Endocarditis due to Bartonella quintana, the etiological agent of trench fever

P. Lagacé-Wiens, Terence C. Wuerz, Carl Boodman, 2020, Canadian Medical Association Journal.

The diabetic foot clinic: not a significant source for acquisition of methicillin-resistant Staphylococcus aureus.

L. Nicolle, T. Hilderman, P. Lagacé-Wiens, 2009, American journal of infection control.

In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019.

J. Karlowsky, P. Lagacé-Wiens, H. Adam, 2021, Diagnostic microbiology and infectious disease.

Antimicrobial susceptibility of 6685 organisms isolated from Canadian hospitals: CANWARD 2007.

M. Mulvey, J. Karlowsky, D. Hoban, 2009 .

Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Canadian hospitals: Results from CANWARD 2007

M. Mulvey, D. Hoban, P. Lagacé-Wiens, 2009 .

Fluoroquinolone resistance in Escherichia coli isolated from patients attending Canadian hospitals is associated with the ST131 clone.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2011, Diagnostic microbiology and infectious disease.

Clostridioides difficile toxin testing and positivity in Manitoba, Canada

C. Righolt, P. Lagacé-Wiens, S. Mahmud, 2020, Infection Control & Hospital Epidemiology.

Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.

J. Karlowsky, D. Hoban, P. Lagacé-Wiens, 2013, The Journal of antimicrobial chemotherapy.

Gardnerella vaginalis Bacteremia in a Previously Healthy Man: Case Report and Characterization of the Isolate

K. Bernard, A. Reimer, T. Burdz, 2007, Journal of Clinical Microbiology.

Pasteurella species peritoneal dialysis-associated peritonitis: Household pets as a risk factor

P. Lagacé-Wiens, J. Embil, M. Verrelli, 2015, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Faculty Opinions recommendation of Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.

P. Lagacé-Wiens, 2009 .